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Juvenile idiopathic arthritis (JIA) is the most prevalent childhood rheumatic disease and 
significantly impacts a child’s well-being by potentially leading to disability and long-
lasting effects. It consists of all forms of arthritis developing before the age of 16, 
therefore  managing this disease is not simple.  JIA can lead to a host of different medical 
problems over time and requires early attention and adequate treatment to prevent these 
long-term consequences.  However, many children still experience pain after traditional 
treatment, indicating a need for alternative treatment modalities.  Exercise therapy is one 
form of treatment that can potentially enhance a child’s quality of life.   
Literature Review Findings 
Multiple forms of exercise therapy have been shown to improve quality of life, functional 
ability and pain in patients with JIA.  Exercise does not worsen disease activity, including 
the number of joints affected.  While there are a limited number of studies in the JIA 
population, studies on patients with rheumatoid arthritis, a rheumatic disease diagnosed 
in adulthood, demonstrate the potential for exercise therapy to alter the pathophysiology 
of the disease and lead to better immune function.  Exercise may have the ability to affect 






The goal of the proposed randomized control trial is to measure the impact of an exercise 
intervention on the quality of life of children with JIA, the effect exercise on participant 
immune function and variations in response between each subtype of JIA.  Children will 
either complete high intensity interval walking training three times a week or no exercise 
intervention for 10 weeks.  Various outcomes including quality of life, functional status, 
pain and fitness level will be measured before and after the intervention.  Blood analysis 
to assess changes in immune function and further analysis between subtypes will also be 
conducted.   
Conclusions 
The use of exercise therapy as a management tool for JIA should be considered earlier on 
in the disease course.  It has not been found to worsen the disease and has produced 
increases in quality of life, functional status and pain.  The benefits of this therapy are 
widespread and are not limited to healthy individuals.   
Significance 
This will be the first time these analyses will be performed and, if improvement is seen, 
this could help guide a physician’s disease management plan.  Data from this study could 
provide information on how exercise modifies the disease and how to design more 
structured exercise programs appropriate to each subtype of JIA.  Exercise may begin to 
be incorporated into the treatment plan for these children to increase disease remission 
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Juvenile idiopathic arthritis (JIA) is a childhood rheumatic condition that has the potential 
to significantly affects a child’s physical and psychosocial health.  JIA is the most 
prevalent chronic illness and cause of disability in children, often extending into 
adulthood.1,2  It is more common in children than both diabetes and epilepsy and 
produces a greater financial burden then asthma.1  It is a general term that includes every 
form of arthritis presenting before age 16.1  Each of the seven subtypes present with 
slightly varying onset age, signs, symptoms and pathophysiology (Figure 1).  JIA affects 
almost any joint and leads to symptoms such as joint stiffness/swelling, fatigue, pain, and 
impaired physical function. This disease can lead to movement and balance issues, 
muscle atrophy, sleep issues, and multiple metabolic and psychological disorders.3,4  
 
Figure 1: Frequency, age of onset, and sex distribution of the International League of Associations for 




Children with JIA often have diminished aerobic and anaerobic exercise capacity, 
such as in jumping, throwing, running and climbing stairs.5  These impairments lead to 
issues completing these simple daily activities at the same pace as healthy children.6  This 
can limit their time participating in physical activities, socializing with friends and 
overall quality of life.6,7  JIA children experience higher levels of stress, anxiety and 
depression, which can further increase pain and disability and can impact the entire 
family.8  
The goal of JIA treatment is to halt disease progression and support normal 
growth and development.  It includes early pharmacological intervention with NSAIDs, 
biologics, steroids and disease modifying agents.9  These treatments come with 
worrisome side effects, such as increased risk of infection, detrimental effects on growth 
and development, and even malignancy.9  Frequently, children are inadequately treated 
and continue to live with debilitating pain as their disease progresses.  This indicates a 
need for alternative therapies and further management to improve quality of life in this 
patient population.9  
The use of non-pharmacological treatments, such as exercise, has been found to 
aid in management of chronic rheumatic conditions and are appealing to parents due to 
the elimination of adverse side effects (ASE).10  Exercise is regularly recommended for 
healthy children due to the numerous physical and mental health benefits.  While initially 
discouraged for individuals with arthritis or other rheumatic disease, regular physical 
activity has been shown to be just as valuable for patients with arthritis or other 




reducing pain, joint stiffness and tenderness in rheumatoid arthritis (RA), a common 
autoimmune disease in adults that share many features with JIA.12  Exercise consistently 
shows positive effects, just like pharmacologic therapy for the disease.4  Studies have 
recently found similar results in children with JIA who include exercise as part of their 
disease management.  Klepper et al. (2007) found that children who performed aerobic 
exercise for at least 30 minutes twice per week for 6 weeks experienced a decrease in 
disease symptoms including joint swelling, pain, and range of motion.13  In addition to 
medical management, non-pharmacological treatment should be considered to possibly 
eliminate the need for polypharmacy, decrease medication dosages and avoid the long 
term complications from ASE.14  
 
Statement of the Problem 
Tremendous focus has been placed on creating the most appropriate and effective 
pharmacological treatment for JIA with the goal of regaining full function and control of 
one’s life and without disease limiting activities of daily living.  Childhood arthritis can 
become a great burden to a child and his/her family and can lead to severe disability and 
progression even into adulthood.2  Many children are highly deconditioned due to 
reduced physical activity and worry exercise will worsen disease.  Their reduced fitness 
further contributes to long term outcomes and level of disability.14  Some of these 
complications are caused by medications themselves: steroids can lead to the 
development of osteopenia, growth arrest, or retardation; disease modifying 




biologics suppress the immune system and can increase chances of infection.1,9  It is 
necessary to identify the disease and develop a treatment plan early to avoid 
complications that may stick with these children for life. 
Non-pharmacological treatments, including exercise therapy, are interventions 
that may reduce disease burden without added ASE.  They can potentially reduce chronic 
medication dosages and extend the duration of remission and potency of disease 
flares.15,16  Currently, only a minority of patients use complementary and alternative 
medicine (CAM), but these treatment modalities are increasing in popularity as more 
research demonstrates the positive effects of these therapies.10  Many children with 
rheumatic conditions are inadequately treated and continue to experience pain even after 
receiving potent medical treatment.9  Exercise has specifically been shown to decrease 
stress on joints and provide many benefits to immune, cardiovascular, muscular and bone 
health.15,16  Additionally, exercise in JIA enhances quality of life and patient capacity 
without side effects.  There is, however, limited data on the effect of exercise on 
immunity and inflammatory markers, the hallmark pathophysiology of an autoimmune 
disease.4  This study aims to understand how not only disease activity and physical 
fitness, but the impact of exercise on a patient's immune function.  
 
Hypothesis 
A high intensity interval walking training program in children with JIA will lead to 
greater changes in quality of life, functional ability and pain level when tested against a 




Objectives and specific aims 
The management of JIA is constantly being studied and is evolving.  The goal is to 
control the disease to allow the child to live a normal life, and to prevent the long-term 
effects and disability.  The mainstay of JIA treatment is medical management, however, 
complementary and alternative medicine, such as exercise therapy, should be integrated 
into the treatment plan to continue to improve overall health.  The goal of this study is to 
identify how exercise can improve quality of life and alter the pathophysiology of the 
disease.  Specifically, this study aims to: 
 
1. Measure the effect of an exercise intervention on the physical and psychosocial 
health of children with JIA. 
2. Measure the effect of an exercise intervention on immune function, a component 
of disease pathophysiology. 












REVIEW OF LITERATURE 
Overview: 
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in 
children, affecting between 148 to 167 per 100,000 with a mean age of onset of 4.8 years.  
Its incidence and prevalence are variable throughout the world and may be 
underestimated.1,17  Previously known as juvenile rheumatoid arthritis (JRA), the 
International League of Associations for Rheumatology (ILAR) adopted the term JIA to 
describe seven forms of arthritis in children that begin before the age of 16 and persist for 
longer than 6 weeks.1,3,18  The term idiopathic indicates that these kinds of arthritis are of 
unknown cause.  Similar to rheumatoid arthritis (RA), the cause of JIA is not completely 
understood.  Studies show these diseases may be linked to genetic or environmental 
factors.  For example, in those with a genetic tendency, the disease could be triggered by 
something in the environment, such as a virus.1,19,20  
JIA Subtypes 
According to the ILAR, JIA is not one disease but rather a broad term that 
includes a group of seven subtypes: systemic JIA (sJIA), oligoarticular JIA, rheumatoid 
factor negative (RF-) polyarthritis, rheumatoid factor positive (RF+) polyarthritis, 
enthesitis-related arthritis (ERA), psoriatic arthritis (PsA) and undifferentiated JIA.18  
While symptoms such as joint swelling, pain, stiffness, muscle weakness and atrophy, 
and movement restrictions are associated with all subtypes of JIA, each is unique.1,3   
Unlike many rheumatologic disorders, sJIA occurs equally in both boys and girls 




one of the following: an evanescent erythematous rash, hepatomegaly, splenomegaly, 
lymphadenopathy, or serositis.  Leukocytosis with neutrophilia can also be seen.21  
Systemic JIA is considered an autoinflammatory process, where the innate immune 
system is activated, leading to inflammation.20  Macrophage activation syndrome is a life-
threatening complication that occurs in about 5-8% of sJIA patients and, therefore, it is 
crucial to recognize and treat this early.  However, in patients with fever without 
preceding arthritis, it can be difficult to establish the diagnosis of sJIA early on.1  
Oligoarticular JIA is an early onset form of JIA peaking at ages 2-4. This form 
affects four or fewer joints during the first 6 months of disease. A review by Ravelli and 
Martini (2007) reports its frequency to be 27-56%, higher than all other forms.1  The 
knee and ankle joints are most commonly affected.  If greater than four joints become 
involved after the initial 6 months, the term extended oligoarthritis is used.  A large 
number of oligoarticular patients have positive antinuclear antibodies (ANAs) and are at 
a higher risk for anterior uveitis, which can lead to long term visual impairment.1  
Rheumatoid factor- (RF) and RF+ polyarthritis affects five or more joints during 
the first 6 months of disease with or without the presence of the IgM RF.  RF+ 
polyarthritis is similar to RF+ adult RA and is most commonly seen in adolescent girls. 
Resembling RA, it most often affects the small joints of the hands and rheumatoid 
nodules develop over the extensor surfaces in a about a third of patients during the initial 
stages of the disease.1,21  In contrast, RF- polyarthritis is less well defined.  It presents 




Enthesitis-related JIA and PsA belong to the collection of spondyloarthropathies, 
a term that also includes children with juvenile ankylosing spondylitis and patients with 
undifferentiated spondyloarthritides.1  Enthesitis-related JIA mainly affects male patients 
after the age of 6.  Both enthesitis and arthritis are seen, most commonly at the calcaneal 
insertion of the Achilles tendon, plantar fascia, and tarsal area.1  A juvenile PsA diagnosis 
is controversial and has been recently reclassified as “other JIA”.  It requires occurrence 
of both a psoriatic rash and arthritis.  If no rash is present, the diagnosis is made using a 
family history of psoriasis, dactylitis, or nail pitting in addition to arthritis.  
Undifferentiated arthritis includes those patients who fit into more than one category.1,21  
The current standard of treatment for JIA consists of use of early pharmacological 
intervention with NSAIDs, biologics, steroids and disease modifying anti-rheumatic 
drugs (DMARDs).  Treatment approach varies between subtypes and is often not 
straightforward.1,9  NSAIDs have been the backbone of treatment for many years, 
however, recently the use of DMARDs earlier on has been shown to prevent long term 
sequelae of the disease.9  Intra-articular steroid use is also increasing earlier in the disease 
course.  Systemic steroid usage is common and used for longer durations in sJIA or those 
with severe polyarticular JIA.22  A multidisciplinary team of rehabilitation professionals, 
physicians and nurses are required to halt disease progression and allow for regular 
growth and development.2,9   
Pathophysiology 
The pathophysiology of JIA is not completely understood but has been discussed 




regulatory cells.  This leads to chronic inflammation of primarily the synovium of the 
joints.20  All subtypes involve triggering of the immune system, whether an 
autoinflammatory response of the innate immune system or an autoimmune response of 
the adaptive immune system.23,24  Each subgroup of JIA involves different components of 
the immune system and variation exists within each. 
Systemic JIA is thought to be an autoinflammatory process from abnormal 
activation of phagocytes of the innate immune system, including monocytes, 
macrophages and neutrophils, due to unknown factors.  These phagocytes release 
proinflammatory cytokines (IL-1, IL-6, IL-18), macrophage colony stimulating factor, 
tumor necrosis factor (TNF-⍺) and proinflammatory S-100-proteins, which contribute to 
multi-systemic inflammation.23,24  There is no definite link between sJIA and HLA genes 
or infection triggering the disease. 
Oligoarticular and polyarticular arthritis are associated with autoimmune reactions 
and an abnormal adaptive immune system.  Proinflammatory Th1 and Th17 cells produce 
the proinflammatory cytokines IFN-γ and IL-17.  Immunosuppressive CD4+ regulatory T 
cells are inhibited and anti-inflammatory cytokine IL-10 is decreased resulting in the lack 
of immune tolerance to self-antigens.  The imbalance between the pro- and anti-
inflammatory cells causes synovitis of the joints.4,23,24  Immune reactions triggered by 
environmental factors in a genetically susceptible patient is associated with the 
development of these types of JIA.  In oligoarticular JIA, positive HLA gene associations 
include HLA-A2, HLA-DRB1*11 and HLA-DRB1*08 exist.  HLA-DR4 is associated 





Similarities and differences in the clinical courses of each JIA subgroup 
exist.  The chronic inflammation seen in JIA manifests as pain, fatigue, decreased fitness 
and activity level, sleep disturbance, diminished bone mineral composition, impaired 
quality of life (QOL) and growth disturbances.  Low IGF-1 levels are seen in all types.1,4  
Packham et al. (2002) investigated the long-term outcomes and functional levels of 246 
patients with JIA that had progressed into adulthood and disease duration averaged 28.3 
years.22  The authors found 43.3% had clinically active arthritis and 54.4% increased C-
reactive protein (CRP).  Severe disability was found in 42.9% of the patients.22   
Functional limitation and joint destruction increased into adulthood due to disease 
exacerbations and recurrent synovitis in affected or new joints.  Persistent oligoarticular 
arthritis patients (fewer than 4 joints involved) have the most superior long-term 
prognosis of all JIA subtypes with higher levels of remission and decreased need for 
rheumatology follow-up.  Therefore, this group, along with other milder forms of JIA 
were underrepresented in this study.  Those that progressed to polyarticular disease 
represented 80% of the study population.  Systemic and RF+ polyarthritis showed the 
worst prognoses with regards to functionality and disability.  Uveitis was seen in 22% of 
the total study group and was significantly related to ANA positivity. A significantly 
higher proportion of those with oligoarticular and extended oligoarticular developed 
uveitis compared to those with systemic and RF+ polyarticular arthritis and 31% of 




Overall, the heights of those with JIA are shorter than the general population with 
a significant relationship between time using steroids and final height.  In the sJIA group, 
30.8% had leg length discrepancies over 2 cm and had undergone total hip replacements.  
Prosthetic joint replacements occurred at a young age and 51.2% of the study population 
had at least one joint replacement.  Micrognathia, which leads to poor mouth opening and 
restricted temporomandibular joint (TMJ) movement, was more frequently seen in sJIA 
than other subtypes.  Amyloidosis was seen in 8.9% of all patients with sJIA the most 
affected.22  
Other long-term outcome studies have shown that between 30 and 56% of patients 
with JIA have serious functional limitation, including joint deformity and destruction, 
growth abnormalities, osteoporosis (from corticosteroid use), pain, impaired psychosocial 
health and difficulties with activities of daily life.22  Furthermore, children with JIA lead 
a more sedentary lifestyle compared to healthy children.  This leads to functional 
deterioration, deconditioning, and further inactivity.5  This cycle can have lasting effects 
on a child’s cardiovascular health.  Kids with JIA are at a higher risk of developing poor 
cardiovascular health and steps should be taken to address this potential outcome early on 
in the disease course.25  
Increased levels of inflammation and increased medication usage over time are 
found in individuals with uncontrolled, active JIA.25  When correlated to healthy 
children, JIA patients with increased disease activity have significantly decreased 




show developmental delays in growth and fine motor skills due to this decreased physical 
activity.7,13   
Exercise is beneficial to many aspects of one’s overall healthy, including having 
an anti-inflammatory affect.4  Thus, exercise therapy is an influential part in treatment of 
a child with any form of JIA.1,2  Simple stretching, repetitive strengthening, and exercise 
as tolerated are generally recommended by rheumatologists.  However, more structured 
and higher intensity exercises are currently being studied in JIA patients for their efficacy 
on decreasing disease progression and improving overall quality of life. 
Exercise therapy and Rheumatoid Arthritis 
Exercise therapy has increased in the adult RA population as well.  RA and JIA 
share similar features but remain distinct diseases.  RH+ polyarthritis shares the same 
characteristis as RF+ RA with differences in disease phenotype seen because of the 
difference in maturity of bone tissue at disease onset.1  RA is the most common 
inflammatory arthritis in adults.  It is also an autoimmune disease in which the cells of 
the adaptive immune system, with contribution from the innate immune system, produce 
antibodies that attack self-antigens in the joints leading to destruction of the synovium, 
joint effusions and pain.  These immune cells, produce pro-inflammatory cytokines (IL-1, 
IL-6, TNF-⍺) and granulocyte-macrophage colony-stimulating factor (GM-
CSF).  Peripheral blood monocytes also move to the synovial tissue and develop into 
macrophages that produce cytokines.  These cytokines contribute to the formation of 
osteoclasts derived from CD14+ monocytes and further immune cell recruitment, which 




fatigue and weight loss, rheumatoid nodules, cardiovascular illness (unexplained by the 
use of corticosteroids), anemia of chronic disease, secondary Sjogren’s syndrome, uveitis, 
increased risk for lymphoma and osteoporosis.28  
As in JIA, the cause of RA is thought to be due to a mix of genetics and 
environmental triggers.28  There is an relationship between the human leukocyte antigen 
(HLA)-DRB1 locus and those positive for RF and anti-citrullinated protein antibody 
(ACPA) antibodies.  Infections producing heat-shock proteins have also been thought to 
trigger the production of RF.28  
Persistent synovitis and limited joint mobility over time leads to further physical 
inactivity, muscle atrophy and decreases in bone mineral density (BMD).12  Joint 
effusions and swelling directly inhibit contraction of surrounding muscle groups and 
affect the biomechanical integrity of the joint.  This leads to pain, altered loading 
responses and patterns of motion that are energy insufficient and further limit 
movement.12  Decreased physical activity along with a high level of clinical disease 
activity and glucocorticoid use contributes to the progession of osteopenia and other 
negative health outcomes.26  Although treatment traditionally indicated rest for affected 
joints, studies show that RA patients are able to tolerate a regular exercise program 
without exacerbating their clinical or immunological disease course.19  A paper by 
Shephard et al. (1997) looked at physical activity and RA and found high CD4+ counts 
and a pro-inflammatory shift in T-cell populations in patients with high levels of RF.19  
The authors reported a decrease in the level of these CD4+ immune cells, enhancement of 




This indicates that exercise increases fitness, while having an effect on the pathogenesis 
and disease course of RA.  
The inflammatory synovitis seen in JIA is consistent with that seen in adult RA 
and produces similar symptoms of swelling, pain and limited joint movement.  Both 
diseases are due to an abnormal production of autoantibodies against self-antigens in the 
synovium, which leads to deformation of cartilage and bone.  In some cases, further 
features including cardiovascular, pulmonary, psychological and skeletal disorders 
occur.23,24,29  Another shared characteristic of these two diseases is the involvement of 
cortisol, a catabolic hormone produced by the adrenal gland.  Cortisol is a powerful anti-
inflammatory agent and is released in response to adrenocorticotropic hormone (ACTH) 
from the pituitary gland.  In RA patients, an impaired response to ACTH has been 
reported with a decrease in cortisol levels and subclinical adrenal glucocorticoid 
insufficiency.  Abnormalities in the hypothalamus-pituitary axis (HPA) have also been 
suggested.  This leads to insufficient cortisol secretion to stop continued inflammation in 
patients not receiving treatment.  Exogenous corticosteroids are successfully used to treat 
patient with RA and JIA.  Since physical activity increases cortisol secretion in healthy 
children, it can be hypothesized that it could also increase cortisol levels in JIA 
children.4,30  Future studies are needed to expand this hypothesis. 
In the realm of JIA, there are few studies that investigate the effect of exercise 
therapy immune function.  A review by Rochette et al. 2015 investigated the effects of 
exercise on the pro/anti-inflammatory effects in JIA patients and suggests a regular 




inflammatory systemic effects.4  It reports the need for more research on this topic to 
determine the intensity and duration of training needed to reach these effects.  This is an 
area of research that could be explored to help further define the benefits of exercise 
therapy in JIA patients.  
Benefits of Exercise Therapy: 
 Chronic musculoskeletal pain (CMP),  a component of JIA, has traditionally been 
treated with rest and avoidance of activities that could trigger further inflammation.19  It 
was thought that increasing pressure on the joints through exercise would worsen pain, 
disease activity, or cause joint destruction.31  Many patients with CMP experience pain-
related fear and avoidance of physical activity which leads to maintenance of pain and 
other disease related symptoms.15  In a study of patients with chronic low back pain, fear 
of injury correlated significantly with disability (r=.44).16  Patients with CMP fear that 
exercise will worsen their disease.  By avoiding exercise, they become deconditioned 
over time.  In theoretical pain research models, physical inactivity is a factor that 
maintains chronic pain.  Reconditioning is used in pain rehabilitation to increase activity 
and reduce disability.15,16  The American College of Sports Medicine recommends 
exercising 3 to 5 days a week to increase cardiorespiratory fitness and body composition.  
Two exercise sessions a week is considered the lower limit of effectiveness, and one 
session is not effective in improving fitness in healthy adults.32  Repeated physical 
activity is as necessary for patients with CMP and rheumatic conditions, such as JIA, as it 




patients with chronic pain is proving physical activity in this patient population should 
not be avoided as it has been. 
 Studies in the adult RA population have shown success and no harmful side 
effects with physical activity.  A systematic review on the effects of dynamic exercise 
therapy program in RA patients showed improvement in physical fitness, range of motion 
(ROM) and function through records of muscle strength and oxygen uptake.  The authors 
recommend an exercise program of aerobic training combined with muscle strength 
training in RA.31  Sandstad et al. (2015) recommended 2-7 days/week of exercise in RA 
patients to improve maximal oxygen uptake (VO2max), maximal heart rate (HRmax) and risk 
of cardiovascular disease (CVD).29 This study showed physical activity to be effective in 
significantly reducing several CVD risk factors, including high blood pressure, total body 
fat, and BMI, and noted it can prolong disability in patients with arthritis.29  
  Exercise has many benefits to one’s physical, emotional and social health.  These 
benefits are not limited to healthy individuals.  Exercise has many anti-inflammatory 
effects and reduces the risk of CVD in RA patients as well.29  CVD is the top cause of 
deaths in the RA population with chronic inflammation and cannot be explained by 
classic CVD predictors alone.25  Children with JIA are also at risk for poor cardiovascular 
health due to decreased activity levels.  They have been shown to have subclinical signs 
of atherosclerosis, including aortic stiffness, in individuals as young as 4 years old.33  
Therefore, prevention of CVD needs attention in both RA and JIA patients due to their 




As in RA, studies have found that exercise in children and adolescents with JIA 
does not increase disease activity or worsen symptoms.13,34  Multiple side effects come 
with each of the pharmacological treatments used to manage JIA, while physical activity 
does not come with any of the serious systemic side effects.34  Children with JIA have 
been found be able to perform land-based weight-bearing or aquatic exercise without 
disease exacerbations.  Other benefits including increased ROM, strength, fitness, 
improved bone health and decreased stress on joints has also been observed after exercise 
in JIA patients.35,36  In general, exercise programs, particularly those including 




JIA and RA have traditionally been treated with modifications of activities of daily 
living, rest of affected body parts and pharmacologically.  Current modalities are 
relatively effective at treating these rheumatologic diseases, however, some patients are 
still refractory to treatment and maintain active disease states without gaining complete 
control of the disease.1,19,38  The goal of treatment is to preserve physical and 
psychological strength, alter long term progression, disability and achieve clinical 
remission.1,28  RA patients have lower fitness levels, movement and balance 
abnormalities and can tolerate and benefit from exercise programs.31  Similar studies in 
children and adolescents with JIA have shown similar benefits.2,3  JIA and RA are the 




warranting further research of non-pharmacological treatment, such as exercise therapy, 
to further investigate its benefits.3,26 
Exercise therapy is also being utilized more often in JIA as it shares similar 
characteristics with RA.  In a review of JIA by Ravelli and Martini (2007), physiotherapy 
is noted to be an important component of the treatment to any patient with JIA.1  They 
also mention that parents tend to protect their children and restrict their activities similar 
to adult RA patients avoiding exercise in fear of injury.1,15  Avoidance of activity not only 
affects a child’s physical fitness and functionality but it can also affect their social skills 
and development of personality.  Restriction from certain activities, such as sports and 
physical activities at school, decreases time socializing with others and can have long 
term effects on emotional and social health.22  Psychological support is yet another 
important part of the multidisciplinary approach to management of JIA.1 
Effect of Exercise Therapy on Juvenile Idiopathic Arthritis 
One of the earliest high quality randomized control trials (RCT) was conducted by Singh-
Grewal et al. (2007) and allocated 80 JIA children, 40 in each arm, to complete a 
program of either high-intensity aerobic cardio-karate consisting of 3 sessions per week 
for 12 weeks (experimental) or low-intensity Qigong non-aerobic exercises (control).39  
The aim of the study was to study peak oxygen uptake, peak power and self-reported 
physical function in JIA patients.  After treatment, no difference was found between 
groups in VO2submax while treadmill walking at 3 km/hour (p=0.43).  A clinically relevant, 
but not statistically significant, decrease in the number of active joints and improvement 




CHAQ scores indicating improved physical function.  However, there was no difference 
between groups potentially indicating no additional benefit from high-intensity aerobic 
training.  Exercise was tolerated well in both groups, though adherence was higher in the 
control.  Although not significant, these results suggest aerobic exercise may only be 
superior in terms of decreasing the number of active joints and increasing ROM.  Both 
exercises are safe and produce clinical benefits, such as improved physical function and 
quality of life.  The non-aerobic group also had higher adherence to the program 
suggesting a decrease in intensity may be easier to comply with while still potentially 
providing benefits to the child’s health.2,3,39  A limitation of this study is the absence of a 
non-exercise cohort.  Without this type of control, one does not know how JIA patients 
would perform without a structured exercise program.  The Hawthorne effect may have 
led to participants showing improvements in the study merely due to the fact they are 
enrolled in a program and being observed. 
Another RCT by Mendonça et al. (2013) studied the impact of Pilates exercises 
on the quality of life in children with JIA.40  A total of 50 participants with JIA, aged 8-
18 years old, were randomly sorted into either a Pilates group (II) or conventional 
exercise group (I)  and completed two 50 minute sessions a week for 6 months.  All 
sessions were supervised and standardized in both groups, strengthening the internal 
validity of this study.40  The Pediatric Quality of Life Inventory (PedsQL 4.0) score was 
used to measure improvement in the primary outcome measure, health-related quality of 
life (HRQOL), at the beginning (t0) and end (t6) of the 6 month intervention.  A 




SD, 37.4 ± 5.1; p < 0.001) and psychosocial (MD ± SD, 36.5 ± 4.3; p < 0.001) PedsQL 
4.0 scores after intervention.  In the Pilates group alone, total PedsQL 4.0 score increased 
by 38.8 points (SD = 3.9; p < .001) from t0 to t6.  The conventional group did not show 
statistically significant improvements.40  Significantly greater improvements in pain 
intensity (MD, 3.1mm; 95% CI, 1.85-4.24; p<0.001), functional ability (MD, 0.83; 95% 
CI, 0.35- 0.91; p < 0.0001) and joint ROM (MD ± SD, 0.10 ± 0.20; 95% CI, 0.001- 0.20; 
p = 0.002) were also found in the Pilates group.  The study had no dropouts, adverse 
effects or worsening of disease activity.  These findings highlight the safety and positive 
impact of an exercise program, such as Pilates, on improving the physical and 
psychosocial quality of life, pain, functional ability, and ROM of a child with JIA.  It 
further strengthens the argument that exercise should become part of disease management 
in children with JIA.2  A limitation the authors noted is that Pilates exercises are more 
motivating which could be a potential confounding factor.  It may have contributed to the 
sense of well-being in those participants in this group and impacted the PedsQL 4.0 
Scores.40  Also, this exercise intervention may not be generalizable when implemented 
unsupervised, at-home due to loss of external motivation. 
Takken et al. (2003) performed a RCT to study the effects of aquatic exercise on 
functional ability in JIA.41  A total of 54 children, 27 in each group, were randomly 
allocated to participate in a structured aquatic exercise program (experimental) or a 
control group that continued to be managed pharmacologically but did not exercise.  
Those in the experimental group completed a 1-hour aquatic session once a week over 6 




Functional Assessment Scale (JAFAS).  HRQOL was measured using the Juvenile 
Arthritis Quality of Life Questionnaire (JAQQ) and the Child Health Questionnaire 
(CHQ), a survey of physical and psychosocial health of children 5 years of age and older 
developed for the general population and children with chronic conditions.42  Joint status 
was measured by the number of tender and swollen joints and physical fitness was 
assessed using a maximal exercise test (MXT) and submaximal 6-min walking test 
(6MWT).41  Although not significant, the experimental group improved 27% in CHAQ 
score while the control group only improved 5% over 6 months.  There was a significant 
relationship between baseline CHAQ score and improvement after intervention (p<0.05) 
in which patients with increased levels of disability benefited the most in the aquatic 
program.41  No significant differences were seen in HRQOL, however, there was a trend 
for the control group to deteriorate while the experimental group remained stable.  The 
number of swollen and tender joints decreased, with a 55% decrease in the experimental 
group and 21% increase in the control group, a clinically significant change, but was not 
statistically significant (p=0.07).  Physical fitness did not significantly change. 
While limited, these results show a clinically but not statistically significant, 
benefit of an aquatic exercise program on the number of tender and swollen joints in JIA 
patients, especially those living with more severe disability and limited functional 
status.  There were no negative effects on disease status or increase in pain indicating this 
type of intervention is safe. 
The frequency of sessions (once per week) is a limitation to this study.   The 




pool access and busy family schedules.  They suggest including a home-based exercise 
component in future studies.  According to the guidelines of the American College of 
Sports Medicine, a minimum of two sessions per week on non-consecutive days is 
regarded as the lower limit to be effective in improving cardiorespiratory fitness and 
body composition in adults.28  An increase to the number of exercise sessions is this study 
may have resulted in significant results. 
A study by Tarakci et al. (2012), investigated if a strengthening exercise regimen, 
primarily unsupervised by health professionals and completed at home, would impact 
quality of life and pain control in children with JIA.43  Participants were randomly 
allocated to either an exercise group or control group that did not exercise.  The exercise 
group completed 4 sessions a week of increasing intensity (1 supervised and 3 
unsupervised at home) over 12 weeks.  At the end of 3 months, outcomes including 6-
minute walk test (6MWT), functional ability using the CHAQ score, pain using the visual 
analogue scale (VAS) along with CHAQ, and QOL using the Pediatric Quality of Life 
Inventory (PedsQL) were assessed.  The 6MWT has been found to be a valid test for 
measuring functional status of children with JIA and requires patients to walk the farthest 
span in 6 minutes.7,43  After intervention, all outcomes measures showed significant 
improvements in the exercise group (p<0.001) and only the VAS decreased significantly 
in the control group (p<0.01).43  The 6MWT increased significantly by 30.79 meters in 
the exercise group while the control group only increased 0.63 meters.  Except for VAS 




significant (p < 0.001) and in favor of the exercise group.  This study had high adherence, 
suggesting the design of this exercise program is feasible for children. 
These results indicate an aerobic, land-based exercise program may benefit the 
functionality and quality of life of patients with JIA by decreasing joint stiffness and 
fatigue, even when completed mostly at home without the supervision of a health 
professional.43  It suggests that an at home design may be more practical and increase 
adherence to exercise and allow for an increase in the number of sessions per week.  For 
example, when compared to the study conducted by Takken et al. (2003), only 1 aquatic-
based exercise session per week was possible.41  CHAQ and QOL were not significantly 
increased and the aquatic intervention was only found to clinically minimize the 
tenderness and amount of swollen joints.41  However, Tarakci found these outcomes were 
significantly increased following exercise, suggesting an increase in quantity of exercise 
may lead to stronger results. 
In another RCT conducted by Sandstedt et al. (2013), muscle strength and 
physical fitness were studied to understand how medically managed JIA patients can 
further improve their health with exercise.42  Significant changes in muscle strength were 
seen and warrant discussion.  In this study, 54 children and adolescents aged 9-21 were 
randomized into an exercise or control group.  Children in the exercise group performed a 
mixture of strength training exercises using free weights and jump rope at home 3 times a 
week, while the control group did no exercise.  Muscle strength, fitness and wellbeing 
were noted before and after a 12-week training program and at a 6-month follow-up.  The 




for shoulder abduction, elbow flexion, hip extension, hip abduction, knee extension and 
ankle dorsiflexion (p<.03).  These improvements illustrate that JIA children can tolerate 
and potentially benefit from a weight bearing exercise program to improve muscle 
strength without increasing pain.42  
Quality of life and well-being were measured using the (CHAQ), and the Child 
Health Questionnaire (CHQ).42  No differences were found between the exercise and 
control group in this study.  However, there has been debate that these questionnaires 
lack sensitivity to changes in rehabilitation.  The ability to detect changes in well-being in 
this study may have been limited by the fact that subjects had only moderate impairment 
and their disease was not active at the time of study.  The authors also point out the 
complexity of JIA pathogenesis and the fact that medical management often does not 
alleviate all symptoms.  Many of the disease’s effects on self-esteem and well-being do 
not respond to traditional medical therapy.  They argue this further supports the idea that 
non-pharmacological interventions such as exercise should be included with medical 
treatment for better outcomes on overall health.42  
A study by Obeid et al. (2015) took a different approach than the studies above 
and looked at the response of peripheral blood levels of endothelial progenitor cells 
(EPCs) to exercise in both healthy and JIA children.25  These cells contribute to vascular 
repair via paracrine secretion of angiogenic factors or differentiation into mature 
endothelial cells.  They are inversely correlated with markers of endothelial dysfunction 
and predict occurrence of cardiovascular events.  They are also known to be decreased in 




of healthy controls.  Untreated RA patients with high levels of TNF-⍺, a marker of 
inflammation, were shown to have lower EPCs compared to the treated and healthy 
patients.  In prior studies, the authors state a single episode of exercise was shown to 
increase peripheral blood endothelial progenitor cells (EPCs) from 66-309% and 83-
170%  in healthy adults and children, respectively.25  This study found resting levels of 
EPCs to be similar in JIA children and healthy controls.  After moderate intensity, 
continuous exercise (MICE), the concentrations of EPCs in healthy controls was 
significantly higher than that of JIA children (p<0.001).  The healthy controls had ~100% 
increase in EPCs while the levels in JIA children did not change.  No change was seen 
after high intensity, intermittent exercise (HIIE) in either group.  The lack of EPC 
increase in JIA children could be a result of disease related inflammation, medication use 
or recruitment of EPCs from the blood to the synovium.25   
These finding suggest JIA patients are at further risk for CV events due a 
decreased EPC response and, thus an understanding of how exercise relates to changes in 
EPC levels in children is warranted.  Furthermore, those in the MICE group completed a 
total of 60 minutes of exercise, while those in the HIIE group only completed a total of 6 
minutes of exercise.  HIIE was designed to mimic the typical physical activity patterns of 
children.25  Since there was no response to HIIE in either group, one could infer that the 
typical activity of a child is not sufficient for change and longer periods of exercise may 
be needed. 
 Overall, these RCTs show no increase in level of pain or clinical deterioration in 




were seen.  However, there is not much data physical activity and its impact on disease 
activity, the immune system and pathophysiology of the disease.  There have been 
stronger exercise intervention studies with promising results in RA patients, a disease 
with similar pathophysiology to JIA.  The results suggest similar research should be 
conducted in patients with JIA.  
Effect of Exercise Therapy on Rheumatoid Arthritis 
In a prospective study by Hakkinen et al. (2001), a group of 70 recent onset RA 
patients were randomly distributed to at-home strength training or control (range of 
motion exercise without resistance) groups.12  Over two years, participants completed 
exercises twice a week, were prompted to participate in exercise-related activities 2-3 
times a week and keep training logs that were inspected every 6 months.  Muscle 
strength, bone mineral density, physical function, joint damage, disease activity and 
walking speed were measured.  The results showed that in the strength training group, the 
maximum strength of all muscle groups examined increased significantly when compared 
to the control (p = 0.002-0.025).  Significant between group differences, in favor of the 
strength training group were observed for clinical disease activity, as measured by ESR, 
pain, morning stiffness, DAS28 and Larsen score (p < 0.05) and HAQ scores at 18 and 24 
months (p < 0.01 and p < 0.05 respectively).  The mean ± SD walking speed increased by 
16 ± 17% (p < 0.001) in the strength training group and by 9 ± 12% (p = 0.025)  in the 
control group.  No significant changes were seen in BMD in either group.12  
The authors of this study also assessed the groups at 5 years to determine if the 




patients, 59 were reassessed and the initial muscle strength gained in the first 2 years was 
maintained after self-monitored exercise over the subsequent 3 years.  BMD remained 
constant and radiographic damage to peripheral joints remained low at 5 years.44  The 
results of this study indicate that with minimally supervised strength training, strength 
and physical function can improve and be sustained in patients with RA without 
worsening the disease.  In those with RA, an increase in muscle strength is important as it 
can decrease risk of falling and increase daily activity levels.12  Decreased activity and 
high levels of disease activity also impact the development of osteopenia.  While BMD 
was not shown to have decreased over the span of 5 years, a limitation of this study is 
that it included only those with a recent (<2 years) diagnosis of RA with mostly normal 
BMD at baseline.44  A study looking at bone mineral density in patients with much older 
RA diagnoses may be more informative regarding the development of osteopenia. 
 A paper by Sandstad et al. (2015) studied the effects of 10 weeks HIIT on a group 
of seven women with RA and eleven women with adult-JIA (age 20-50 years with 
disease diagnosis in childhood).29  The study was designed as a cross-over study with 
patients acting as their own controls.  After the first period of training or control, a two 
month “washout period” occurred.  Thomsen et al. (2018) defines HIIT as organized 
cardiorespiratory training with multiple rounds of short duration intervals at 80-95% of 
HRmax followed by intervals of lower intensity as active recovery.45  HIIT has been 
shown to improve cardiovascular health so this study tried to determine whether a HIIT 
intervention could be physically managed by patients with RA and would lead to 




spin bikes at 85-95% of HRmax twice a week for 10 weeks.  Maximum oxygen uptake, 
heart rate recovery (1-minHRR), blood pressure, body composition, blood biomarkers 
(lipid panel, white blood cell count, C-reactive protein), disease activity calculated by 
DAS28, and functional disability, assessed by the Stanford health assessment 
questionnaire (MHAQ), were measured before and after intervention.  After intervention, 
VO2max increased by 12.2% (p<0.001), 1-minHRR increased 2.9% (p=0.02), BMI, total 
body fat, and waist circumference decreased by 1.2% (p=0.04), 1.0% (p=0.04), and 1.6% 
(p=0.004), respectively, while no change was observed in the control group.29  Blood 
analysis revealed serum levels of ferritin (a biomarker for inflammation) decreased 
24.0% (p=0.006).  A clinical, but not statistically significant, decrease in CRP from 1.98 
to 1.23 (p=0.08) was seen, reflecting less joint inflammation.  No differences were seen 
in disease activity and pain in either group.29   
Overall, this study demonstrated no negative effects on RA and adult-JIA patients 
who underwent a high intensity exercise program and showed significant improvements 
in CVD risk factors.  Sandstad et al. (2015) showed a 12% increase (4.4 ml/kg/min) in 
VO2max indicating RA and JIA patients respond to exercise and decrease their risk of all-
cause mortality and CV events similar to healthy individuals.29,46  Furthermore, slow and 
abnormal 1-minHRR is associated with inflammatory markers and contributes to 
CVD.  This study found significant improvements in 1-minHRR after intervention and 
improved CVD risk factors.29   
The main limitations of this study were the small sample size and cross-over 




study population.  Participants randomized to the HIIT group first may have experienced 
long-term benefits during the subsequent control period.29  This was the first study to 
look at HIIT in rheumatologic patients and the authors conclude HIIT to be a favorable 
alternative treatment for patients with RA and adult-JIA.29  This study was able to 
establish that regular physical activity is beneficial for those with arthritis, similar to the 
general population.  HIIT can improve pain, function, mood and QOL and delay the onset 
of disability without worsening disease severity.11,29  
A recent RCT by Thomsen et al. (2018) also looked at the effects of a HIIT 
exercise program but in a cohort of patients with psoriatic arthritis, another type of 
inflammatory arthritis and one of the subtypes of JIA.45  Its goal was to evaluate the 
impact of HIIT on disease activity and patient disease perception.  At the end of the trial 
period, the HIIT group reported less fatigue, as measured by the patient global 
assessment (PGA), than the control group (mean difference of -12.83; 95% CI -25.88 to 
0.23, p = 0.05) and HIIT showed no clear increase of disease activity with psoriatic 
arthritis.  After 3 months, patients completed exercise on their own time.  These results 
were not maintained at 9-month follow-up with low continued adherence to exercise. 
This indicates a challenge for health care providers to continue to set exercise goals and 
keep their patients active.45  Although no long term effects of HIIT were shown, this 
study, as well as Sandstad et al. (2015), provides strong evidence against the idea that 
vigorous physical exercise leads to increased disease activity.29,45  
It is clear from the studies discussed above that, similar to JIA, physical activity is 




in disease activity and physical function by monitoring outcomes such as QOL, number 
of affected joints and pain.  However, they did not investigate whether exercise affects 
the pathology of the disease.  Luo et al. (2018) studied the correlation of CD64 
expression on monocytes in patients with RA with markers of autoimmune response, 
inflammation, disease activity and serum cytokines.26  In comparison to healthy 
individuals, the occurrence of these monocytes was significantly elevated in RA patients.  
Classical (CD14++CD16-, regulators of inflammation) and intermediate (CD14++ 
CD16+, proinflammatory role) monocytes were elevated and positively correlated with 
ESR, CRP, RF, ACPA and DAS28, all indicative of inflammation in RA.  Intermediate 
monocytes were also found to be associated with serum concentrations of IL-6, a 
proinflammatory cytokine.26  These findings suggest the classical and intermediate 
monocyte elevation impact the progression of RA and positively correlate with disease 
activity. 
Bartlett et al. (2018) utilized this information and applied it to RA patients in an 
exercise program.47  The authors studied the effects of a high-intensity interval training 
program in older adults with stable RA and found exercise correlated with a lower level 
of disease activity and improved immune function in RA patients.47  The goal of the 
study was to determine whether 10 weeks of walking-based HIIT would improve disease 
activity and aerobic fitness and whether HIIT was associated with improved immune 
function.  They specifically look at antimicrobial/bacterial functions of neutrophils, cells 
that dominate the synovial fluid, and monocytes, cells that infiltrate the synovium.  Both 




addition to the proinflammatory cells in the joint, characterize the pathology of RA.47  
RA is a disease that leads to an impaired immune system and is often treated with 
immunosuppressive drugs that further increase the risk of opportunistic infections.  The 
authors sought to find ways to avoid further suppression of the immune system.  They 
argued that since exercise improves immune function in healthy adults, it had the 
potential to improve immune function in RA.47  The authors found a significant increase 
in cardiorespiratory fitness, as measured by VO2peak, by a mean ± SD of  9 ± 4% 
(p<0.001), reduction in resting HR (p = 0.009) and reduction of mean arterial BP (p = 
0.044).  They found a 38% reduction in disease activity, as measured by DAS28, due to a 
decrease in the number of swollen and tender joints and improved global health ( 
p=0.001).  A significant reduction in ESR by a mean of 58% was also found (p = 0.02).47  
The intervention also improved innate immune function, indicating a potential 
reduced risk of infection and inflammation.  Neutrophil movement of isolated RA 
peripheral blood neutrophils toward chemokine ligand CXCL-8 increased (p=0.003), as 
well as phagocytosis of Escherichia coli (p=0.03) and ROS production (p<0.001).  There 
were also significant decreases in the prevalence of both nonclassical CD14+ CD16+ and 
intermediate CD14++CD16+ monocytes (both p<0.05).26,47  These results suggest 
exercise has the potential to enhance antibacterial function and reduce risk of 
infection/inflammation.  A limitation of this study is the lack of an age-matched healthy 
control group.  A comparison between an experimental and control group would produce 







This multi-site RCT study will articulate the effectiveness of 10 weeks of HIIT walking 
for strengthening physical and psychosocial health in children with JIA, while also 
investigating the differences noted between subtypes of JIA.  Furthermore, it will assess 
whether this intervention is associated with improved immune function.  
 
Study Population and Sampling 
The participants recruited for this trial will be 5- to 18-year-old children diagnosed with 
any type of JIA in accordance with the ILAR criteria and on stable dosage of 
medication/treatment consisting of nonsteroidal anti-inflammatory drugs, disease 
modifying anti-rheumatic drugs, immunosuppressive medication, and/or steroids.  During 
the 6-month period prior to enrollment in the study, participants will not have followed 
any standardized exercise program.  Patients will be excluded from the study if they 
have: significant cardiac, pulmonary, rheumatologic, or metabolic comorbidity; active 
disease that requires therapy modification during study; any medical condition 
determined by their physician to be a contraindication for physical exercise; or take 
opioid pain medication.  Also, those who are unable to walk unaided on a treadmill or 
miss 3 consecutive training sessions during intervention period will be excluded from the 





The sample size and power were calculated using the UCSF Clinical and 
Translational Science Institute sample size calculator with data from a study of JIA 
patients by Tarakci et al (2012).43,48  An effect size of 20.6, the mean difference between 
the exercise and control group, and the exercise group’s higher SD of 14.23 points were 
chosen for a more conservative estimate.43  An estimated sample size of 18 patients, 9 in 
each group is needed to detect this difference between the exercise and control groups 
with 80% power, an ⍺ of 5%, and a 1:1 intervention to control proportion.43,48  This study 
will have a larger sample size of estimated 150 patients, 75 in each group, with the goal 
of recruiting higher numbers of patients from each of the different subtypes of JIA for 
analysis between subtypes.  The sites included will be Boston Medical Center in Boston, 
MA, Boston Children’s Hospital in Boston, MA, Cincinnati Children’s Hospital Medical 
Center in Cincinnati, OH, Ann & Robert H. Lurie Children’s Hospital of Chicago in 
Chicago, IL, and Hospital for Sick Children in Toronto, Ontario, Canada.  Multiple sites 
were chosen due to the larger sample size. 
 
Intervention Groups 
The participants will be randomly assigned to either the HIIT walking group (Group I) or 
control group (Group II) with no supervised exercise intervention. One case will be 
randomized for each control.  Both groups are to continue their regularly prescribed 
medications and standard of care.  Participants will be randomized by two Boston 
Medical Center (BMC) research assistants blinded to all data regarding patients’ 




Microsoft Excel spreadsheet while the another staff member will randomly allocate each 
number to a patient from a list containing names of participants ordered based on date of 
recruitment.  The list will then be securely delivered to the research team.  Patients 
assigned numbers 1-75 will comprise group I and numbers 76-150 will comprise group 
II. 
 Physicians and those responsible for administering fitness testing, data collection 
and statistical analysis will also be blinded to the study.  All participants and their 
parent/guardians will be instructed to not discuss study to other possible participants.40  
Exercise training (Group I)  
Over the course of 10 weeks, group I members will participate in high-intensity interval 
walking.  As stated above, a child’s day to day activities are of anaerobic nature, so HIIT 
was chosen to mimic this.6  Training will consist of 3 x 30-minute sessions per week of 
treadmill walking for a total of 30 planned sessions per patient.  Each training session 
will be performed with supervision of an exercise physiologist trained to administer the 
same level of encouragement across all locations.  Interventions will be standardized to 
avoid variation at each location and increase internal validity.  During each training 
session, heart rate (HR) will be measured using Polar H10 heart rate sensors given to 
each patient enrolled in the study.  These are Bluetooth compatible with iOS mobile 
devices with iOS 11 or later and Android mobile devices with Bluetooth 4.0 capability 
and Android 5 or later.  Exercise physiologists will ensure HR remains in target zones as 




For the exercise intervention, VO2 reserve was chosen to represent cardiovascular 
fitness and will be calculated using percentage of maximal HR (%HRmax) as previously 
described.10  Patients will be given between 3-6, 20 minute sessions to become 
accustomed to exercise.  Exercise sessions will be 30 minutes and consist of a 5-minute 
warm-up, ten 60-second high intensity intervals, each followed by 60-second active 
recovery, and a 5-minute cool-down.  High intensity intervals are designed to elicit a 
HRmax of 85 ± 5%, corresponding to 80-90% of VO2 reserve, followed with active recovery 
periods of 50-60% VO2 reserve.  Treadmills will not exceed walking pace, and if patient 
is unable to achieve HR goal by walking at 1%, treadmill gradient will be increased to 
elevate HR.  This design was adapted from Bartlett et al. (2018).47  
Control (Group II) 
The control group will be administered all tests described below before and after a 10-
week period.  During this time period, they will be instructed to continue with their 
normal disease management routine as per their rheumatologist. 
 
Study Variables and Measurement Tools 
Baseline characteristics, including demographics, JIA subtype, disease state, and 
medications will be collected from each patient's’ electronic medical record (EMR) at 
each hospital location.  A fasting blood sample will be collected in both groups at 
baseline to measure complete blood count differentials using a commercial clinical 




 All outcomes will be assessed, as below, before and after 10-week intervention 
for members of both groups.  Testing will be finished prior to starting training and 24 
hours or more after group 1 finishes its last exercise session. Group II will be measured at 
the beginning and end of a 10-week period. 
The primary outcome, health related quality of life (HRQOL) will be measured by 
the PedsQL 4.0 in interview format.  Designed and modified by Varni et al. (2003), the 
PedsQL 4.0 assesses pediatric physical, emotional, social and school functioning.49  It is 
specifically tailored to pediatric rheumatology and a reliable and valid tool for assessing 
pediatric QOL.  Scores range from 0-4 with higher scores representing better quality of 
life.  Functional ability will be measured by the CHAQ, a frequently used functional 
health status measure in children with JIA, in interview format which takes 
approximately 10 minutes to obtain.  CHAQ is scores range from 0-3, and higher scores 
reflect greater disability.14  Pain intensity will be measured using the 10-cm VAS-joint 
pain scores ranging from 0-10, with 0 representing no pain and 10 representing the worse 
pain.  This scale has been shown to be reliable and valid when evaluating JIA patients.50  
Cardiorespiratory fitness, measured by VO2peak will be assessed by continuous 
walking test on a treadmill starting at 2mph/0% grade with speed or incline increasing 
each minute until individual reaches fatigue.  No specific increase in speed or incline will 
be used as fitness levels may vary.  An exercise physiologist will supervise these tests 
and increase speed or incline based on the child’s heart rate, respiratory exchange ratio 
and overall appearance.  A 12-lead electrocardiogram, ventilation, and gas exchange will 




Metabolic Cart (Parvo Medics, Sandy, UT, USA).  Highest 20-second values will be used 
to determine VO2peak.  A child will have met VO2peak criteria when RER > 1.1 and age-
predicted maximal HR are met.39,47 
Blood tests including, ESR and CRP will be performed on blood samples by 
hospital lab.  ESR and CRP are standard markers of inflammation but are subject to 
variation from many causes.  To further assess immune function and inflammatory 
potential, peripheral blood mononuclear cells will be isolated by Ficoll-Plaque density 
gradient centrifugation.  CD14 and CD16 monocyte surface receptor expression will be 
determined after cells are stained, incubated and analyzed by flow cytometry.47 
 
Recruitment 
Patients and their parent/guardian will be offered to participate in this study by pediatric 
rheumatologists at each participating hospital.  These rheumatologists will be informed of 
the study via email from their department chair.  Patients with any subtype of JIA are 
eligible for enrollment.  After agreeing to participate in this study, the patient and his/her 
parent/guardian will be informed of all aspects of study by a research assistant, including 
goals and design, and formal informed written consent will be obtained.  Patients will 
then be examined by their rheumatologist and primary care physician to assure they meet 
inclusion and exclusion criteria of the study.  Recruitment will close when appropriate 
sample size is achieved.  Recruitment within each subtype of JIA may not be equal due to 






Participants in both groups will be assessed by a pediatric rheumatologist before and after 
the 10-week intervention period to obtain clinical characteristics, health and disease 
activity and medication use.  Research assistants will access EMR and enter data into 
REDcap, an online research data management tool that is both secure and meets HIPAA 
compliance standards.   
A trained research assistant will administer and then score the PedsQL 4.0, 
CHAQ and 10-cm VAS-joint pain tests in interview format to patients at time of 
rheumatology clinic visits.  Electrophysiologists will supervise the fitness testing and 
enter VO2peak into EMR.  Results of ESR and CRP blood tests will be reported by hospital 
labs and CD14 and CD16 monocyte surface receptor expression will be reported from 
outside facilities.  Blood samples will be prepared promptly for plasma and immune cell 
isolation, and compatible samples will be stored at - 80℃ until analysis.  All scores and 
testing results will be uploaded to EMR and added to REDcap by research assistants.   
 
Data Analysis 
Baseline characteristics will be collected and recorded as mean ± SD, n (%) and 
values in groups I and II will be compared to determine whether there are any statistically 
significant differences in patient characteristics between the two groups prior to 
intervention (Table 1).  The outcome measurements discussed above will assess the 
patient's response to exercise intervention.  Pre-HIIT and post-HIIT QOL, functional 




mean ±  SD and a student T-test will be used to detect variation between groups I and II 
before and after intervention.40,47  
All plasma analyses were adapted from Bartlett et al. (2018) and will be 
completed before and after HIIT intervention.47  CRP and ESR will be log-transformed 
and reported as mean ±  SD and a student T-test will be performed before and after 
intervention.47  
Further analysis will be performed to determine if there is variation between 
subtypes of JIA.  The pathophysiology of sJIA is thought to be due to an 
autoinflammatory process while oligoarthritis and polyarthritis are thought to be due to 
an autoimmune process.  Within groups I and II, participants will be sorted based on JIA 
subtype.  PedsQL, CHAQ and 10-cm VAS-joint pain will be reported as mean ±  SD.  
Analysis as described above will be performed on each subgroup looking for subtype 
specific change in effect sizes after exercise intervention.  A limitation of this analysis is 
a low recruitment number in some subtypes of JIA. Figure 1 shows the frequency of each 
and illustrates variation between subtypes.  We estimate that this study will have 
sufficient power for a total sample size of 18 patients, 9 in each group.   By increasing the 
sample size to 150 higher recruitment may allow for analyses within subtypes to reach 
statistical significance.  All statistical testing will be conducted by a trained statistician 







Table 1: Baseline Characteristics 
Variable Group I (n = 75) 
Summary Statistic 
Group II (n = 75) 
Summary Statistic 
Comparison Between 
Groups: Statistical Test  
Age (year) Mean ± SD Mean ± SD T-test 
Female  N (%) N (%) Chi-square test 
Schooling    
    Elementary N (%) N (%) Chi-square test 
    Secondary N (%) N (%) Chi-square test 
JIA Subtype    
    Systemic N (%) N (%) Chi-square test 
    Oligoarticular N (%) N (%) Chi-square test 
     Polyarticular RH+ N (%) N (%) Chi-square test 
     Polyarticular RH- N (%) N (%) Chi-square test 
    Enthesitis-related N (%) N (%) Chi-square test 
    Psoriatic N (%) N (%) Chi-square test 
    Undifferentiated N (%) N (%) Chi-square test 
Diagnosis age (Y) Mean ± SD Mean ± SD T-test 
Active disease N (%) N (%) Binomial test for a 
difference of proportions 
Medications    
    NSAID N (%) N (%) Binomial test for a 
difference of proportions 
    DMARD N (%) N (%) Binomial test for a 
difference of proportions 
    Biologic N (%) N (%) Binomial test for a 
difference of proportions 
    Systemic Steroids N (%) N (%) Binomial test for a 
difference of proportions 
White Blood Cells    
    Total Count Mean ± SD Mean ± SD T-test 
    Neutrophils Mean ± SD Mean ± SD T-test 
    Lymphocytes Mean ± SD Mean ± SD T-test 
    Monocytes Mean ± SD Mean ± SD T-test 




Timeline and Resources: 
An ongoing study in children with juvenile fibromyalgia, another chronic pain syndrome 
in children, is also studying an exercise intervention.  It is evaluating whether a combined 
cognitive behavioral therapy (CBT) and neuromuscular exercise training program is more 
effective in reducing disability compared to CBT or a graded aerobic exercise alone (3 
groups).  It is a multi-site RCT with an estimated enrollment of 420 participants.  It has 
an actual start date of January 2, 2018 and estimated study completion date of January 
2023.51  
 The current study is also a multi-site RCT with only two groups and a smaller 
sample size. Since the prevalence of JIA is greater than that of juvenile fibromyalgia, it is 
reasonable to estimate the current study will require three years for recruitment and trial 
completion.1,52  Following submission and approval by the IRB, recruitment will be 
ongoing over the first two years.  Participants will be able schedule initial rheumatologist 
visits and undergo initial testing as soon as they have been evaluated for inclusion criteria 
by their primary care physician.  Participants will not be required to complete 10-week 
intervention concurrently, however, the intervention will be standardized for each patient 
as described above. 
 Pediatric rheumatologists at each hospital location must be informed and agree to 
participate in study.  Trained research assistants must be available for delivering PedsQL, 
CHAQ and 10-cm VAS-joint pain scales at rheumatology clinic appointments before and 
after 10-week intervention.  Lab technicians must be available at participating hospital 




scheduled for each participant in group 1 to complete three supervised HIIT walking 
sessions.  Exercise physiology labs must have access to treadmill, heart rate monitor, and 
parvo medical cart.  Each participant in group 1 will be given a Polar H10 heart rate 
sensors. Group II participants will use lab heart rate monitors configured to their 
individual settings.  An estimated three exercise physiologists will be needed at each 
hospital location to supervise an estimated five sessions, three days a week.  This number 
was calculated assuming the 75 group II participants will be split equally between 
locations and completed their sessions on the same days and over the same 10-week time 
span.  This number may vary by location based on recruitment time and size.  Study 
investigators at each location will collect data from labs and afterwards complete 
analysis.    
 
Institutional Review Board: 
The study protocol involves interaction and intervention with human subjects and 
involves accessing private information.  Therefore, it will be submitted for IRB review to 
the Boston University Medical Campus IRB under INSPIR II criteria due to the 
noninvasive study design.  This study qualifies for expedited review because the design is 
of minimal risk and it requires collection of data through a noninvasive procedure and 











The goal of this study is to determine the effect of a HIIT walking exercise program on 
children with JIA by analyzing QOL, functional ability, disease activity, 
cardiorespiratory fitness and various inflammatory markers.  The cause and 
pathophysiology of this disease is not fully understood and these children often require 
multiple medications with serious side effects.  Some do not reach clinical disease 
remission and are inadequately treated, indicating a need for alternative 
therapies.  Exercise is regularly recommended to healthy children and leads to numerous 
physical and mental health benefits.  It has been shown to be as beneficial in patients with 
other rheumatic disease as it is in healthy individuals.  For this reason, it should be 
recommended to children with JIA and be incorporated into the standard of care. 
 Most studies of exercise therapy in JIA use small samples, most recruiting only 
around 50 participants.  A strength of this study is its larger sample size of 150 patients.  
With a larger sample size, randomization will more likely be successful.  This study also 
aims to analyze the effects of exercise within the subtypes of JIA, something that has not 
previously been done.  Due to differences in the pathogenesis implies different treatment 
strategies may be needed, making this type of analysis valuable.  This study will help 
determine which subtypes benefit from exercise therapy and, thus, in which it should be 
considered for treatment.  Furthermore, the current study analyzes serum samples from 




phenotypes associated with inflammation.  This is the first time these types of analyses 
will be done on patients with JIA. 
 This study design requires those in group 1, the exercise group, to come to a 
hospital 3 times per week for supervised HIIT walking.  Each child’s HR will be 
monitored throughout the entire 30-minute session and maintained in goal ranges.  While 
this will allow us to analyze the maximum effects of this intervention,  it is not 
generalizable.  The design of this study, HIIT, was chosen to mimic the anaerobic nature 
of a child’s day to day activity.  However, outside of a controlled research setting, most 
children will not wear HR monitors and achieve the same exercise intensity, leading to 
smaller effects.  Furthermore, the intervention may have limited generalizability due to a 
potential sampling bias as not all children with JIA will have parents who can afford to 
bring their child into the hospital three time a week for this therapy.  If we do not see 
significant outcomes from the current study, it is unlikely children will benefit with less 
controlled, at home exercise regimes. 
 There are several limitations to this study, particularly related to assessment of 
QOL, functional ability and pain, all of which are measured by patient interview.  A 
reporting bias is present.  When patients give consent to be a part of this clinical trial, it is 
not possible to blind them to treatment due to design of the intervention.  Quantitative 
results based on serum analysis are less likely to be influenced by this bias.  Although 
participants will not be blinded, those collecting data and performing analyses will be 
blinded. This eliminates any interviewer bias, as well as bias during statistical analysis to 




Maintenance of results after the study completion may be a challenge, due to the 
intensive nature of the study design and close monitoring of each participant.  The results 
may be difficult to maintain at home.  This occurred in the study Thomsen et al. (2018) 
and is possible with the current study.  The intensive study design may also lead to 
dropouts if a patient misses more than three sessions. 
Another possible obstacle is the recruitment of enough participants in each 
subtype of JIA to allow for appropriately powered analysis.  Some subtypes may not be 
analyzed due to low recruitment.  This study only includes patients who have the ability 




Exercise can lead to a variety of benefits in children with JIA based on research reviewed 
here.  Exercise has consistently been recommended to healthy children and adults and 
should not be limited in children with chronic disease.  The notion that exercise will 
worsen disease state and activity is changing due to the results of the newly published 
research in this field.  The studies reviewed included a variety of exercise interventions, 
including therapeutic exercises (aerobic, muscle strengthening, flexibility), water and 
land-based sports, weight-bearing activities and mind-body exercises, such as Pilates.  All 
measured varying health outcomes including pain, physical function, quality of life, 
disease activity and ROM.  Many showed significant positive results and none showed 




The study proposed here will go one step further and look for a decrease in the 
number of inflammatory CD14++CD16+ intermediate monocytes, which have been 
shown to be involved in the pathophysiology in RA.  In a study of patients with RA, 
these were shown to significantly decrease following HIIT walking training.  Due to 
similarities in the pathophysiology of the two diseases, a similar finding is possible in 
children with JIA.  Regardless of the benefit of exercise on immune function, this study 
can highlight the importance of using an exercise intervention as part of JIA 
management.  If no decrease is found in the number of inflammatory monocytes 
following intervention, it is highly likely we will see an increase in other outcomes based 
on previous research and the low sample size needed to detect difference in this study. 
This study also aims to analyze the difference in outcomes within the subtypes of 
JIA.  The proposed pathophysiology of subtypes varies and may lead to different 
responses.  Oligoarticular and polyarticular JIA are considered autoimmune diseases, 
while systemic JIA is considered an autoinflammatory disease and involves systemic 
features along with joint disease.  With this information, clinicians will have a better 
understanding of when to recommend exercise therapy and who is most likely to benefit 
based on the child’s disease type. 
 
Clinical and/or Public Health Significance 
Juvenile idiopathic arthritis is the most common chronic rheumatic disease in children 
and a significant cause of short- and long-term disability.  It encompasses all forms of 




shown between 40-60% of patients achieve clinical remission, but many carry the disease 
with them into adulthood.  The disease burden can be tremendous on a child’s physical, 
mental and social health and the effects extend to a child’s family.  Prediction of long 
term outcome is imperfect, however indicators of poor outcome include greater severity 
or extension of arthritis at onset, symmetrical disease, early wrist or hip involvement, 
presence of RF, persistent active disease and early radiographic changes.1  It is crucial to 
diagnose and treat the disease promptly to prevent its progression. 
The management of JIA includes a combination of medications with multiple side 
effects.  Physical, occupational and psychological treatments are often used.  The goal of 
therapy is to control the disease by allowing the child to resume normal activities of daily 
living and prevent any long-term disability that may arise.  The use of structured exercise 
therapy early on in the disease will potentially decrease the need for added medications, 
many of which have side effects with long lasting effects.  It may also prolong remission 
and decrease severity of disease flares which can lead to permanent joint damage and 
joint surgeries or replacement later on in life. 
This study has the potential to show exercise should not be avoided, but 
encouraged in JIA.  The results may indicate that exercise not only improves quality of 
life but also can alter the pathophysiology of the disease.  Parents who may shy away 
from activity with the thought that it will worsen their child’s disease may begin to 
encourage it.  The results may also be used to help tailor a management plan specific to 
each subtype of disease.  There is a clear need for further treatment beyond typical 




 With further data on how exercise therapy modifies the disease, more structured 
exercise programs may become a mainstay of treatment. They could become incorporated 
into a multidisciplinary care plan for children with JIA earlier in the disease course to 
increase remission rates, reduce the number and severity of disease flares in addition to 
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